Amazing to see this with the slow volume we've had, but not entirely surprising with a company like VYCO. Word is getting out!

It's further off, but I'd say that's because it was projected to ramp up in 2013

I think that's putting it mildly. They've got a solid plan, product(s), and business; awareness can only help.

There's bound to be a few who'll dump what they've got for beer money or a more volatile play; some people just prefer the vegas method of investing.

Yes, this is a long one until the word really gets out. No day-trader flippers here, just patient investor anticipation.

We've already got the longs holding their shares, now word needs to get out to the budget investors. Seed will spring up just about anywhere, as the parable goes.

Even with proper investor backing, it's going to take time to convince the scientific community that NV really works. You'd think that with 14 independent clinical studies backing it, that it'd catch on faster, but it appears old beliefs die hard.

Well, it's not the ideal, but it once again proves that dips don't last long for VYCO.

Yeah. The Harbinger report alluded several times to plans that the company had for the future. It's like a kid waiting for Christmas, you know it's coming, but you just want it to be here now.

Good to see that spread has tightened again. Some volume would be nice, but it shows that investors are holding on to what they have.

"Over fifteen years of clinical research, it has been shown that in approximately 70% of cases patients using NovaVision's VRT system over a three to six month period experience significant recovery in at least one functional outcome. In many cases this
recovery is enough to restore lost abilities such as reading, avoiding unseen objects while walking, or in some cases even driving a car"

VYCO .016 x .018

Morning all. Let's see some green!

Exciting to see that the ask is now above the first resistance, now about that bid..

The explanation of a "Strong Buy" from the Harbinger Research website:

Decent action today. Nothing like last Friday, but it shows this one's ability to rebound quickly.

Sweeet. Remember what I said about raising your bid?

VYCO rated "strong buy" in independent report. Get your cheapies now!

http://a.eqcdn.com/harbingerresearch/media/b767cf61ff1d00bcf70bf414fab946a5.pdf

From the looks of it, you might be there awhile. ;)

Absolutely. From the Harbinger Report:

Yeah, the company they bought out had already invested 50 mil in developing the technology. He knows when to pick em.

True, and I'd gather that there's quite a few investors waiting on the bid as well. For every seller, there's several buyers.

Good to see we're holding after a shake-out. The dips really don't last long.

The dips don't last long in these parts.

Nearing power hour, let's get back in black.

Come on, tap that ask already!

A few reasons to pay attention to this one:

-200% increase in revenues in a $20B international market
-Strong international patent suite to proprietary technology
-Legit endorsement from medical and scientific community. They have Harvard Med School Profs on the advisory board
-Technology that literally restores sight to the blind and makes inoperable brain procedures possible, 2000 medical procedures already performed
- Market gaining momentum WITHOUT promo's. 14xs the average volume -Competition is largely non-existent
-VBAS lauded in peer reviewed journals at Johns Hopkin's University, Cleveland Clinic, University of Illinois as technically superior
- Over fifteen years of clinical research, it has been shown that in approximately 70% of cases patients using NovaVision's VRT system over a three to six month period experience significant recovery in at least one functional outcome. In many cases this
recovery is enough to restore lost abilities such as reading, avoiding unseen objects while walking, or in some cases even driving a car.

Good morning all.

Good info.

VYCO lull didn't last, not with technology like this:

http://player.vimeo.com/video/39903199

Actually TC, I find it encouraging that VYCO can recoup 30% in a few hours. The sellers may sell, but the buyers will buy.

.016 x .018 That's more like it.

VYCO back in the saddle after a short lull:

Do I spy a spike?

VYCO taking a breather, get in while it's cheap


-200% increase in revenues in a $20B international market
-Strong international patent suite to proprietary technology
-Legit endorsement from medical and scientific community. They have Harvard Med School Profs on the advisory board
-Technology that literally restores sight to the blind and makes inoperable brain procedures possible, 2000 medical procedures already performed
- Market gaining momentum WITHOUT promo's. 14xs the average volume
-Competition is largely non-existent
-VBAS lauded in peer reviewed journals at Johns Hopkin's University, Cleveland Clinic, University of Illinois as technically superior

Time to get the word out on the general boards. More eyes need to view this beaut.

VYCO quiet before the storm

VYCO poised to bounce.
"Vycor Medical Has Breakthrough Product Offerings in the Neurosurgical and Stroke-Related Vision Rehabilitation Markets. We Expect Strong Sales Growth in Late 2012 and 2013, and See Sustainable Hyper-growth Potential in 2014
and Beyond."
-Harbinger Research

.013 x .018 VYCO split won't last long.


-200% increase in revenues in a $20B international market
-Strong international patent suite to proprietary technology
-Legit endorsement from medical and scientific community. They have Harvard Med School Profs on the advisory board
-Technology that literally restores sight to the blind and makes inoperable brain procedures possible, 2000 medical procedures already performed
-Watching market OG's quietly staking big claims WITHOUT promo's. 14xs the average volume
-Competition is largely non-existent
-VBAS lauded in peer reviewed journals at Johns Hopkin's University, Cleveland Clinic, University of Illinois as technically superior

Pick up the VYCOcheapies while they last!